Last reviewed · How we verify
NCT04550078
The Postprandial Calcium Absorption of a Milk Derived Calcium Permeate - RENEW Acute Study
NA trial testing Calcium Carbonate in Osteoporosis in 10 participants. Completed in 6 November 2020.
6 November 2020
Quick facts
| Lead sponsor | Inge Tetens |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 10 |
| Start date | 22 July 2020 |
| Primary completion | 6 November 2020 |
| Estimated completion | 6 November 2020 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Calcium Carbonate (calcium carbonate) — full drug profile →
- Calcium Permeate
- Placebo
Conditions studied
- Osteoporosis — all drugs for Osteoporosis →
Sponsor
Inge Tetens
Who can join
Adults 50 to 65, female only, with Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled cross-over meal study with the overall aim to investigate the postprandial calcium absorption from calcium permeate compared with calcium carbonate. The hypothesis is that the bioavailability of calcium permeate is equal to or higher than calcium carbonate. This will be investigated in a cross-over design with 10 postmenopausal women age 50-65 as subjects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04550078
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Calcium Carbonate
Trials testing the same drug.
- NCT06352775 — Calcium Carbonate on Labor Induction · NA · active not recruiting
- NCT03634917 — Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test fo · Phase 3 · completed
- NCT03425747 — Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism · Phase 4 · completed
- NCT05109390 — A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adu · Phase 1 · completed
- NCT03113994 — Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk · Phase 2 · terminated
Other recruiting trials for Osteoporosis
Currently open trials in the same condition.
- NCT07027306 — The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fract · recruiting
- NCT07367776 — Patient Education in Osteoporosis (RCT-PATOS) · NA · recruiting
- NCT06731608 — OsteoPorotic fracTure preventION System (OPTIONS) Research Study · NA · recruiting
- NCT07281586 — Step-down Therapy After Long-term Osteoporosis Treatment · Phase 4 · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
Other Inge Tetens trials
Trials by the same sponsor.
- NCT05600530 — Validity and Reproducibility of Dietary Assessment Against Objective Measures · completed
- NCT04764526 — Ice Cream Enriched With Protein and Positive Emotions · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04550078 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inge Tetens
- Last refreshed: 17 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04550078.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing